ABOUT MENAP SMI

Our Vision, Mission and Objectives

Our Vision

MENAP-SMI (Middle East, North Africa, Pakistan Self Medication Industry) is a not-for-profit organization which represents manufacturers of non-prescription medicines, food supplements and self-care medical devices (all also designated as Consumer Health Products), based in the MENAP region.

Our Mission

The mission of MENAP-SMI is to promote better health through responsible self-medication and personal well-being.
MENAP-SMI works to creating a partnership with governments and other stakeholders and acts in the best interests of patients, consumers, and industry.

Conduct scientific research, economic analysis & communication actions promoting responsible self-medication
Provide strategic support to members and be the self-medication industry representative vis a vis the official bodies in MENAP region
Organize meetings and conferences with key stakeholders in the self-care industry
Cooperate with public authorities, local and regional associations linked to self-care industry

Universal health coverage ensures all people, everywhere, can access quality essential health services.

Why is self-care so important to attain universal health coverage?

The Role of Self-Care in
Universal Health Coverage

What is UHC, and why is it important?

Universal health coverage (UHC) ensures all people, everywhere, can access quality essential health services with financial protection. It is firmly rooted in the human right to health and requires strong political leadership. Because affordable, accessible, quality health services unlock people’s potential, UHC is one of the smartest investments countries can make. And nearly all countries, including low income countries, have the capacity to mobilise the resources required to achieve UHC. Achieving UHC is essential for inclusive development, prosperity, gender equality and fairness.

View Full PDF

THE ECONOMICS OF SELF-CARE

AFAMELA example

Study Overview and objectives

In order to demonstrate the potential economic and societal benefits of an increase in the number and variety of OTC medicines for consumers and patients in Mexico, Bayer commissioned a study (Sep-Dec´16) to quantify the cost differences between OTC self-care versus the costs for treatment through Mexico’s public health systems for several common, non-serious conditions.

View AFAMELA Study